[Ruby_E_Template slug="buzzstream-header"]
Font ResizerAa
Brinks ReportBrinks Report
Search
  • Featured
  • Money Matters
  • Business
  • IPL
  • Technology
  • Automobile
  • Entertainment
  • Sports
  • More
    • People
    • World
    • Health and Wellness
    • Horoscope
  • Today’s News
Have an existing account? Sign In
Follow US
© 2024-2025 Brinks Report. All content, including text, images, and other media, is copyrighted.
Business

Morepen Labs Expands Overseas with New Entity in Dubai Free Zone

Dolon Mondal
Last updated: June 19, 2025 10:55 am
Dolon Mondal
Morepen Labs

Morepen Labs isn’t slowing down. In a bold move to scale its global game, the Indian pharmaceutical giant has launched a wholly owned subsidiary in Dubai — Morepen Labs FZCO.

This new venture will focus on trading medicines and pharmaceutical products, outside the UAE, marking a strategic shift to deepen its international footprint. Morepen Labs subscribed to 5,000 ordinary shares of AED 10 each, totaling AED 50,000. With this, the company signals that it’s not just playing local anymore. It’s aiming higher.

Why Dubai? Because it’s the ultimate global hub — perfect for reaching Europe, Africa, and Asia from one place. And Morepen wants in.

A Company With Global Grit

Morepen Labs is no newbie in the pharma world. It’s a vertically integrated, innovation-first company that creates APIs, branded generics, medical devices, and wellness products. Right now, they serve over 80 countries — and Dubai just unlocked more doors.

The new setup is also a related party, as it’s 100% owned by the parent company. That keeps control tight, and vision tighter.

Also Read Despite 133% Profit Jump, Inventurus Drops as 10 Cr Shares Hit Market

Behind the Headlines: A Tough Quarter

Even bold moves come with challenges. In Q4 FY25, Morepen’s net profit dropped 28.18% to Rs 20.31 crore. That’s despite a 10.11% jump in revenue, which hit Rs 465.85 crore. So yes, the company is still growing — but it’s navigating some bumps.

Markets noticed. The Morepen Labs stock fell 2.29% to Rs 62.23 on the BSE. But if this Dubai deal delivers, sentiment could flip fast.

What This Means Going Forward

Morepen Labs isn’t waiting for luck. It’s building scale, one region at a time. By setting up base in Dubai, it’s chasing smoother exports, better trade routes, and stronger business connections.

If you’re following India’s rise in pharma, this is a story to watch. This move speaks volumes — about ambition, strategy, and intent. And Morepen’s not hiding any of it.

From here, it’s about execution. Will Dubai become Morepen’s global launchpad? Time will tell. But one thing’s clear — they’re not here to play small.

Also Read Tata Tech Secures Volvo Deal as ‘Strategic Supplier’; Stock Rebounds After 6-Day Drop

TAGGED:Dubai subsidiaryMorepen Labs
Previous Article Tata Technologies Tata Tech Secures Volvo Deal as ‘Strategic Supplier’; Stock Rebounds After 6-Day Drop
Next Article Tesla Showdown in Texas: Democratic Lawmakers Try to Block Tesla’s Robotaxi Rollout!
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

Network18 FY25 News Revenue Grows, Digital Shines
BusinessEconomy

Network18 FY25: News Revenue Rises 4.3%, EBITDA Doubles Despite Slow Ad Market

By Ankita Das
Nykaa
Business

Nykaa Shares Rise 2% After Q1 Update – Buy, Sell, or Hold Now?

By Dolon Mondal
Blue Star Q4 Profit Up 21% from Last Year; Announces ₹9 Dividend Per Share
BusinessEconomy

Blue Star Q4 Results: Profit Up 21% from Last Year and also Announced ₹9 Dividend Per Share

By Ankita Das
United Spirits
Business

United Spirits Down 5%, Sula Up 12%: Maharashtra Excise Duty Hike Reshapes Liquor Stocks

By Dolon Mondal
[Ruby_E_Template slug="buzzstream-footer"]